Improved chemokine homing enhances CAR T–cell therapy for osteosarcoma - EurekAlert
Improved chemokine homing enhances CAR T--cell therapy for osteosarcoma
Pan-cancer analysis uncovers a new class of promising CAR T–cell immunotherapy targets - EurekAlert
Do cutting-edge CAR-T-cell therapies cause cancer? What the data say Regulators have identified around 30 cases of cancer linked to this blockbuster treatment. But is CAR T to blame? The hunt is on for answers.
